Zydus Lifesciences Limited Strategic Asset Allocation Index
Zydus Lifesciences Limited strategic asset allocation index. Zydus Lifesciences Limited (ZYDUSLIFE) has a Strategic Asset Allocation Index of 35.8% as of September 2022. Strategic assets (PP&E of Rs67.22 Billion plus long-term investments of Rs-) total Rs67.22 Billion, measured against net assets of Rs187.68 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check tangible net worth ratio of Zydus Lifesciences Limited to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Zydus Lifesciences Limited (2020–2022)
Strategic asset allocation index of Zydus Lifesciences Limited from 2020 to 2022. This chart shows how Zydus Lifesciences Limited's Strategic Asset Allocation Index has evolved across 3 annual periods from 2020 to 2022. As of September 2022, the index stands at 35.8%, representing strategic assets of Rs67.22 Billion against net assets of Rs187.68 Billion INR.
Zydus Lifesciences Limited Strategic Asset Allocation Index by Year (2020–2022)
Zydus Lifesciences Limited strategic asset allocation index by year from 2020 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Zydus Lifesciences Limited from 2020 to 2022, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see ZYDUSLIFE market cap.
| Year | SAAI | Strategic Assets (INR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 33.7% | Rs64.23 Billion | Rs64.23 Billion | Rs- | Rs190.54 Billion | ▼ -8.7 pp |
| 2021 | 42.4% | Rs63.33 Billion | Rs63.33 Billion | Rs- | Rs149.30 Billion | ▼ -10.5 pp |
| 2020 | 52.9% | Rs61.94 Billion | Rs61.94 Billion | Rs- | Rs117.10 Billion | — |